Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials

BACKGROUND: Respiratory syncytial virus (RSV) is a seasonal infection affecting most children by 2 years of age and the leading cause of lower respiratory tract infection requiring hospitalization in infants. Novel antiviral medications are in development to improve the clinical outcomes of RSV; how...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Patient Rep Outcomes
Main Authors: Lewis, Sandy, DeMuro, Carla, Block, Stan L., Senders, Shelly, Wisman, Paul, Toback, Seth, Chien, Jason W., Williams, Valerie
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2018
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935018/
https://ncbi.nlm.nih.gov/pubmed/29757334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41687-018-0034-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares